+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viscosupplementation Injection Market - Global Forecast 2026-2032- Product Image
Viscosupplementation Injection Market - Global Forecast 2026-2032- Product Image
Sale

Viscosupplementation Injection Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125279
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Viscosupplementation Injection Market is projected to reach USD 3.98 Billion in 2026. It is expected to continue growing at a CAGR of 7.17%, reaching USD 6.05 Billion by 2032.

Viscosupplementation Injection: Executive Overview

Viscosupplementation injection refers to intra-articular administration of hyaluronic-acid-based products intended to supplement synovial fluid and support symptom management in degenerative joint conditions, particularly osteoarthritis. Clinical use is shaped by patient selection, injection technique, product characteristics, treatment pathways, reimbursement policies, and the evolving evidence base regarding pain relief and functional improvement. This executive summary examines the market through clinical, regulatory, geographic, demographic, technological, and strategic lenses without presenting market estimates or forecasts.

Clinical Evidence and Care-Pathway Shifts Reshape Adoption

The landscape is shifting from procedure-centered use toward more integrated osteoarthritis management. Clinicians increasingly evaluate viscosupplementation alongside exercise therapy, weight management, physical therapy, analgesics, corticosteroid injections, and surgical referral. Evidence remains heterogeneous across products, patient subgroups, and study designs, making guideline positioning and shared decision-making important. Adoption is also influenced by injection frequency, duration of symptom relief, tolerability, administration settings, and requirements for prior conservative treatment. Regulatory scrutiny, payer policies, and attention to appropriate-use criteria continue to encourage more selective patient targeting.

Artificial Intelligence Supports Selection, Imaging, and Follow-Up

Artificial intelligence is contributing to the broader musculoskeletal care ecosystem rather than replacing clinical judgment. Potential applications include radiographic grading, identification of structural progression, symptom-pattern analysis, treatment-response prediction, appointment triage, and documentation support. In viscosupplementation pathways, validated models could help distinguish patients more likely to benefit from injection-based care and identify those requiring alternative interventions. However, clinical utility depends on representative datasets, transparent validation, protection of patient information, interoperability with clinical systems, and prospective evidence demonstrating improved outcomes. Leaders should treat AI as a decision-support capability subject to medical-device, privacy, and bias controls.

Regional Insights: Reimbursement and Access Define Divergent Pathways

North America is characterized by specialist-led care, payer variation, utilization controls, and strong attention to comparative clinical evidence. Latin America reflects uneven access, private-sector participation, and differences in specialist availability and reimbursement. Europe combines established orthopedic practice with country-specific health-technology assessment, guideline, and procurement environments across the European Union and neighboring markets. The Middle East shows concentrated demand in major urban healthcare systems, while the Gulf Cooperation Council can support adoption through sophisticated private and public providers. Africa remains highly heterogeneous, with affordability, supply continuity, trained injectors, and diagnostic access shaping utilization. Asia-Pacific spans advanced systems such as Australia, Japan, and South Korea alongside rapidly expanding but uneven healthcare capacity, producing varied routes to diagnosis and treatment.

Group Insights: Economic and Regulatory Blocs Create Distinct Priorities

ASEAN markets are influenced by differing reimbursement structures, healthcare infrastructure, import requirements, and specialist capacity, making local partnerships and adaptable distribution important. BRICS countries combine large and diverse patient populations with substantial variation in public coverage, domestic manufacturing, regulatory procedures, and urban-rural access. The European Union places emphasis on coordinated safety expectations while retaining national differences in reimbursement and clinical guidance. G7 countries generally exhibit mature clinical infrastructure, sophisticated evidence requirements, and greater use of multidisciplinary osteoarthritis management. GCC members benefit from concentrated healthcare investment and cross-border patient flows, whereas NATO markets span diverse health systems but share strong interest in supply resilience, regulated devices, and clinical quality.

Country Insights: Local Policy and Practice Shape Patient Access

Australia emphasizes evidence-based care within a universal health framework, while Brazil combines public and private pathways with pronounced regional variation. Canada’s provincial health policies influence access and coverage, and China’s large healthcare system is shaped by regulatory modernization, hospital procurement, and uneven regional capacity. France, Germany, Italy, and Spain operate within Europe’s structured but nationally differentiated reimbursement and guideline environments. India combines expanding orthopedic services with substantial out-of-pocket payment and rural access constraints. Japan and South Korea have aging populations, advanced clinical infrastructure, and distinctive reimbursement and practice frameworks. Mexico reflects mixed public-private delivery and variable specialist availability. Russia’s access is influenced by procurement, regional healthcare capacity, and broader supply considerations. The United Kingdom is shaped by National Health Service pathways, local commissioning, and evidence-based clinical guidance. The United States has substantial specialist capacity but marked variation in payer coverage, prior authorization, and site-of-care economics.

Strategic Priorities for Evidence, Access, and Responsible Growth

Industry leaders should prioritize product-specific clinical evidence that clearly defines responder populations, meaningful endpoints, durability, and comparisons with relevant nonoperative alternatives. They should align education with appropriate patient selection, injection technique, infection prevention, contraindication screening, and realistic expectations. Market access strategies should be tailored to national reimbursement rules, health-technology assessment requirements, procurement practices, and private-pay dynamics rather than assuming a uniform pathway. Supply planning should address temperature control, traceability, clinician training, and continuity of sterile products. Digital and AI initiatives should use validated models, explainable outputs, cybersecurity safeguards, and human oversight. Finally, organizations should monitor guideline changes, real-world outcomes, adverse-event reporting, and disparities in access to support responsible adoption.

Research Methodology: Structured Review of Clinical and Market Context

This executive summary uses a structured, qualitative assessment of the viscosupplementation injection landscape. The approach considers peer-reviewed clinical evidence, professional guidelines, regulatory communications, reimbursement and health-technology assessment principles, healthcare-delivery characteristics, demographic trends, and technology developments. Findings are organized across the required regions, economic and political groups, and countries to identify common drivers and local differences. Because no underlying quantitative source set was provided beyond the market reference, the analysis intentionally excludes market estimates, market sizing, shares, forecasts, and unsupported numerical claims. Insights should be supplemented with current local regulatory, clinical, and payer documentation before commercial or clinical decisions are made.

Conclusion: Selective, Evidence-Led Integration Will Determine Progress

Viscosupplementation injection remains part of a broader, evolving strategy for managing osteoarthritis symptoms. Its role is determined less by a single global pattern than by the interaction of evidence quality, patient characteristics, clinician expertise, reimbursement, regulation, and healthcare access. Regional and country differences make localized engagement essential, while AI and digital tools offer opportunities to improve selection and follow-up only when appropriately validated. Industry leaders can strengthen the field by investing in transparent evidence, responsible education, reliable supply, and patient-centered integration with nonoperative care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Viscosupplementation Injection Market, by Product Type
7.1. Introduction
7.2. Cross Linked Hyaluronic Acid
7.3. Non Cross Linked Hyaluronic Acid
8. Viscosupplementation Injection Market, by Application Site
8.1. Introduction
8.2. Hip
8.3. Knee
8.3.1. Bicompartmental
8.3.2. Tricompartmental
8.3.3. Unicompartmental
8.4. Shoulder
9. Viscosupplementation Injection Market, by Patient Age Group
9.1. Introduction
9.2. Adults
9.3. Elderly
9.4. Geriatric
10. Viscosupplementation Injection Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Clinics
10.3.1. Orthopedic Clinics
10.3.2. Rheumatology Clinics
10.4. Hospitals
11. Viscosupplementation Injection Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Viscosupplementation Injection Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Viscosupplementation Injection Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Viscosupplementation Injection Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Anika Therapeutics, Inc.
16.2. Bioiberica S.A.U.
16.3. Bioventus, Inc.
16.4. Chugai Pharmaceutical Co., Ltd.
16.5. Diaco Biofarmaceutici S.r.l.
16.6. Ferring Pharmaceuticals A/S
16.7. Fidia Farmaceutici S.p.A.
16.8. Hoffmann-La Roche Ltd.
16.9. I+MED S.r.l.
16.10. IBSA Institut Biochimique SA
16.11. IBSA Poland sp. z o.o.
16.12. Johnson & Johnson
16.13. Kyowa Hakko Kirin Co., Ltd.
16.14. LG Chem Ltd.
16.15. Maxigen Biotech Inc.
16.16. Ono Pharmaceutical Co., Ltd.
16.17. Sanofi S.A.
16.18. SEIKAGAKU CORPORATION
16.19. Zimmer Biomet Holdings, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Viscosupplementation Injection Market, Years Considered for the Study
FIGURE 2. Global Viscosupplementation Injection Market, Research Design
FIGURE 3. Global Viscosupplementation Injection Market, Research Framework
FIGURE 4. Global Viscosupplementation Injection Market, Data Triangulation
FIGURE 5. Global Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Viscosupplementation Injection Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Viscosupplementation Injection Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Viscosupplementation Injection Market Size, by Application Site, 2025 vs 2032 (%)
FIGURE 9. Global Viscosupplementation Injection Market Size, by Application Site, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Viscosupplementation Injection Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Viscosupplementation Injection Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Viscosupplementation Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Viscosupplementation Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Viscosupplementation Injection Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Viscosupplementation Injection Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Viscosupplementation Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Viscosupplementation Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Viscosupplementation Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Viscosupplementation Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Viscosupplementation Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Viscosupplementation Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Viscosupplementation Injection Market Segmentation & Coverage
TABLE 2. Global Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Cross Linked Hyaluronic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cross Linked Hyaluronic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cross Linked Hyaluronic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Non Cross Linked Hyaluronic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Non Cross Linked Hyaluronic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Non Cross Linked Hyaluronic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 11. Global Hip Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Hip Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Hip Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Knee Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Knee Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Knee Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Bicompartmental Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Bicompartmental Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Bicompartmental Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Tricompartmental Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Tricompartmental Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Tricompartmental Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Unicompartmental Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Unicompartmental Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Unicompartmental Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Shoulder Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Shoulder Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Shoulder Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 30. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Elderly Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Elderly Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Elderly Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 40. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Orthopedic Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Orthopedic Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Orthopedic Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Rheumatology Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Rheumatology Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Rheumatology Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 56. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Viscosupplementation Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Viscosupplementation Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. North America Viscosupplementation Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. North America Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. North America Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 77. North America Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 78. North America Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 79. North America Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. North America Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 81. North America Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. Latin America Viscosupplementation Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Latin America Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. Latin America Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 85. Latin America Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 86. Latin America Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 87. Latin America Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Latin America Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 89. Latin America Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Europe Viscosupplementation Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Europe Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. Europe Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 93. Europe Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 94. Europe Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 95. Europe Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Europe Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 97. Europe Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Middle East Viscosupplementation Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Middle East Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Middle East Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 101. Middle East Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 102. Middle East Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 103. Middle East Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Middle East Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 105. Middle East Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Africa Viscosupplementation Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Africa Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Africa Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 109. Africa Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 110. Africa Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 111. Africa Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Africa Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 113. Africa Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Global Viscosupplementation Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. ASEAN Viscosupplementation Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. ASEAN Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 118. ASEAN Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 119. ASEAN Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 120. ASEAN Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. ASEAN Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 122. ASEAN Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. GCC Viscosupplementation Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. GCC Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. GCC Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 126. GCC Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 127. GCC Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 128. GCC Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. GCC Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 130. GCC Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. European Union Viscosupplementation Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. European Union Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. European Union Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 134. European Union Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 135. European Union Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 136. European Union Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. European Union Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 138. European Union Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. BRICS Viscosupplementation Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. BRICS Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. BRICS Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 142. BRICS Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 143. BRICS Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 144. BRICS Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. BRICS Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 146. BRICS Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. G7 Viscosupplementation Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. G7 Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. G7 Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 150. G7 Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 151. G7 Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 152. G7 Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. G7 Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 154. G7 Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. NATO Viscosupplementation Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. NATO Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. NATO Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 158. NATO Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 159. NATO Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 160. NATO Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. NATO Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 162. NATO Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. Global Viscosupplementation Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. United States Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 165. United States Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. United States Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 167. United States Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 168. United States Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 169. United States Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. United States Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 171. United States Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Canada Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 173. Canada Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. Canada Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 175. Canada Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 176. Canada Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 177. Canada Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Canada Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 179. Canada Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Mexico Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 181. Mexico Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Mexico Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 183. Mexico Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 184. Mexico Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 185. Mexico Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Mexico Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 187. Mexico Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Brazil Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 189. Brazil Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. Brazil Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 191. Brazil Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 192. Brazil Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 193. Brazil Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Brazil Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 195. Brazil Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. United Kingdom Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 197. United Kingdom Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. United Kingdom Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 199. United Kingdom Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 200. United Kingdom Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 201. United Kingdom Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. United Kingdom Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 203. United Kingdom Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. Germany Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 205. Germany Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. Germany Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 207. Germany Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 208. Germany Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 209. Germany Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Germany Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 211. Germany Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. France Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 213. France Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. France Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 215. France Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 216. France Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 217. France Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. France Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 219. France Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Russia Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 221. Russia Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Russia Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 223. Russia Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 224. Russia Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 225. Russia Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Russia Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 227. Russia Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Italy Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 229. Italy Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. Italy Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 231. Italy Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 232. Italy Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 233. Italy Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Italy Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 235. Italy Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Spain Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 237. Spain Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Spain Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 239. Spain Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 240. Spain Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 241. Spain Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Spain Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 243. Spain Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. China Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 245. China Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. China Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 247. China Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 248. China Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 249. China Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. China Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 251. China Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. India Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 253. India Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. India Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 255. India Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 256. India Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 257. India Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. India Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 259. India Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Japan Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 261. Japan Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. Japan Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 263. Japan Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 264. Japan Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 265. Japan Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Japan Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 267. Japan Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Australia Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 269. Australia Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Australia Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 271. Australia Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 272. Australia Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 273. Australia Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Australia Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 275. Australia Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. South Korea Viscosupplementation Injection Market Size, 2017-2032 (USD Million)
TABLE 277. South Korea Viscosupplementation Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. South Korea Viscosupplementation Injection Market Size, by Application Site, 2017-2032 (USD Million)
TABLE 279. South Korea Viscosupplementation Injection Market Size, by Knee, 2017-2032 (USD Million)
TABLE 280. South Korea Viscosupplementation Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 281. South Korea Viscosupplementation Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. South Korea Viscosupplementation Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 283. South Korea Viscosupplementation Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Global Viscosupplementation Injection Market Share, by Key Player, 2025
TABLE 285. Global Viscosupplementation Injection Market, Key Experts

Companies Mentioned

  • Anika Therapeutics, Inc.
  • Bioiberica S.A.U.
  • Bioventus, Inc.
  • Chugai Pharmaceutical Co., Ltd.
  • Diaco Biofarmaceutici S.r.l.
  • Ferring Pharmaceuticals A/S
  • Fidia Farmaceutici S.p.A.
  • Hoffmann-La Roche Ltd.
  • I+MED S.r.l.
  • IBSA Institut Biochimique SA
  • IBSA Poland sp. z o.o.
  • Johnson & Johnson
  • Kyowa Hakko Kirin Co., Ltd.
  • LG Chem Ltd.
  • Maxigen Biotech Inc.
  • Ono Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • SEIKAGAKU CORPORATION
  • Zimmer Biomet Holdings, Inc.

Related Topics

Related Reports

Viscosupplementation Market - Global Forecast 2026-2032 - Product Image

Viscosupplementation Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Viscosupplementation - Global Strategic Business Report - Product Image

Viscosupplementation - Global Strategic Business Report

  • Report
  • 385 Pages
  • Global
From
Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2026-2034 - Product Image

Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From
Viscosupplementation Treatment for Arthritis Market Report 2026 - Product Image

Viscosupplementation Treatment for Arthritis Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Viscosupplementation Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Viscosupplementation Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.